Sunday, 4 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US

Legal / IP

  • Company
  • Drug
  • Deals
  • Policy / Regulatory
  • Medical Device
  • R&D
  • Digital
  • Legal / IP
  • Others
  • Hospital
  • General/Other
AstraZenecaBoehringer Ingelheim

Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA

The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First…

August 25, 2026
WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

August 26, 2026

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market

July 22, 2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Novartis to Defend Entresto Patent After CAFC Ruling
CVDNovartis

Novartis to Defend Entresto Patent After CAFC Ruling

January 14, 2025
SynCardia's Next-Generation Artificial Heart Granted Patent in China
CVDPatents

SynCardia’s Next-Generation Artificial Heart Granted Patent in China

January 10, 2025
Roche’s Evrysdi Receives Patent Term Extension in China, Extending Protection to 2035
PatentsRoche

Roche’s Evrysdi Receives Patent Term Extension in China, Extending Protection to 2035

November 27, 2024
BeiGene Reaches Patent Settlement with MSN Pharmaceuticals for Brukinsa
BeiGeneBeOne Medicines

BeiGene Reaches Patent Settlement with MSN Pharmaceuticals for Brukinsa

January 6, 2025
Show More
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up